Understanding the Alcohol and Other Drug (AOD) patient journey to improve treatment access and engagement in care

Understanding the Alcohol and Other Drug (AOD) patient journey to improve treatment access and engagement in care

The challenge

Each year, Alcohol and Other Drugs (AOD) are involved in more than 137,000 hospital admissions but it can take 18 years (on average) for somebody experiencing problems with a substance to seek treatment. Many then face barriers to remain engaged in AOD treatment.

Working closely with NCHA’s Data Platform team, this project sought to improve treatment journeys by identifying effective pathways for connecting and retaining patients in the AOD treatment system in the Frankston and Mornington Peninsula region.

Our impact

  • A co-developed policy map with people with lived experience outlining six recommendations to improve access to AOD care through health and community services.
  • Reducing Alcohol and Other Drugs (AOD) harms through understanding patient pathways into and through AOD treatment.
  • Driving practice change across hospitals and AOD treatment services.
  • Combining big data from the NCHA with qualitative methodologies, and consumer involvement in the research.

Project leads

Led by Professor Suzanne Nielsen, Deputy Director of The Monash Addiction Research Centre (MARC).

-

Project resources & knowledge

-

-

Project team members – Understanding the Alcohol and Other Drug (AOD) patient journey to improve treatment access and engagement in care


-

Key project information

-

For further information please contact Professor Suzi Nielsen: Suzanne.Nielsen@monash.edu or Dr Tina Lam: Tina.Lam@monash.edu